Fundz

KÄÄPÄ Biotech

Southwest Finland, Finland · Biotechnology, Dietary Supplements, Health Care

KÄÄPÄ Biotech is a biotechnology company that researches, innovates and develops functional mushroom products, has three divisions: KÄÄPÄ Forest, KÄÄPÄ Mushrooms and Nordic Mushrooms. KÄÄPÄ Forest manages the largest chaga cultivation network in the world and promotes versatile use of forests. KÄÄPÄ Mushrooms provides customers with Finnish origin organic mushroom extracts. Nordic Mushrooms is a w

You have opened 5 full company profiles today. Create an account to keep reading them. Create an account

Key facts

Headquarters
Southwest Finland, Finland
Employees
23
Industries
Biotechnology, Dietary Supplements, Health Care
Status
Private
Website
kaapabiotech.com
LinkedIn
Company page

Recent activity at KÄÄPÄ Biotech

About KÄÄPÄ Biotech: questions and answers

What does KÄÄPÄ Biotech do?

KÄÄPÄ Biotech is a biotechnology company that researches, innovates and develops functional mushroom products, has three divisions: KÄÄPÄ Forest, KÄÄPÄ Mushrooms and Nordic Mushrooms. KÄÄPÄ Forest manages the largest chaga cultivation network in the world and promotes versatile use of forests. KÄÄPÄ Mushrooms provides customers with Finnish origin organic mushroom extracts. Nordic Mushrooms is a w

Where is KÄÄPÄ Biotech headquartered?

KÄÄPÄ Biotech is headquartered in Southwest Finland, Finland.

How many employees does KÄÄPÄ Biotech have?

KÄÄPÄ Biotech has about 23 employees.

What is the latest news on KÄÄPÄ Biotech?

On Nov 13, 2025, Kääpä Biotech secures €9 million investment led by PeakBridge to enhance production capacity and market presence in the global nutraceuticals sector.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches KÄÄPÄ Biotech across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.